Upregulation of human epidermal growth factor receptor 2 (HER2) in breast cancer cells enhances the expression of fatty acid synthesis genes such as ACC1 and FASN, which are suppressed by PI3K and mTOR inhibitors, indicating that PI3K/AKT/mTOR can regulate fatty acid synthesis [72]. Here, ERBB2 is linked to breast cancer.